Far upstream sequences regulate the human prolactin promoter transcription

Neuroendocrinology

Volumn 71, Issue 2, 2000, Pages 124-137

  Van De Weerdt, Cécile ^a   Peers, Bernard ^a   Belayew, Alexandra ^a   Martial, Joseph A ^a   Muller, Marc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Human; Lactotropes; Lymphocyte; Molecular neuroendocrinology; Pit 1; Prolactin; Prolactin promoter

Indexed keywords

DEOXYRIBONUCLEASE I; PROLACTIN; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENETIC TRANSFECTION; HYPOPHYSIS; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSCRIPTION REGULATION;

EID: 0033955684     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054528     Document Type: Article

References (45)

1. Nelson C, Albert VR, Elsholtz HP, Lu L-W, Rosenfeld MG: Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 1988;239:1400-1405.
2. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L, Nelson C, Elsholtz H, Rosenfeld MG: A pituitary POU demain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 1989;3:946-958.
3. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants, which lack three pituitary cell types, result from mutations in the POU domain gene, Pit-1. Nature 1990;347:528-530.
4. Nelson C, Crenshaw EB, Franco R, Lira SA, Albert VR, Evans RM, Rosenfeld MG: Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes. Nature 1986;322:557-562.
5. Peers B, Voz ML, Monget P, Mathy-Hartert M, Berwaer M, Belayew A, Martial JA: Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol Cell Biol 1990;10:4690-4700.
6. Berwaer M, Peers B, Nalda AM, Monget P, Davis JRE, Belayew A, Martial JA: Thyrotropin-releasing hormone and epidermal growth factor induce human prolactin expression via identical multiple cis elements. Mol Cell Endocrinol 1993;92:1-7.
7. Caccavelli L, Manfroid I, Martial JA, Muller M: Transcription factor AP-1 is involved in basal and okadaic acid stimulated activity of the human prolactin promoter. Mol Endocrinol 1998;12:1215-1227.
8. Nalda AM, Martial JA, Muller M: The glucocorticoid receptor inhibits the human prolactin gene expression by interference with Pit-1 activity. Mol Cell Endocrinol 1997;134:129-137.
9. Pernasetti F, Caccavelli L, van de Weerdt C, Martial JA, Muller M: Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Mol Endocrinol 1997;11:986-996.
10. Dimattia GE, Gellersen B, Bohnet HG, Friesen HG: A human B-lymphoblastoid cell line produces prolactin. Endocrinology 1988;122: 2508-2517.
11. Gellersen B, Bonhoff A, Hunt N, Bonnet HG: Decidual-type prolactin expression by the human myometrium. Endocrinology 1991;129: 158-168.
12. Pelligrini I, Lebrun J-J, Ali S, Kelly P: Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992;6:1023-1031.
13. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Aarkins S, Kooijam R, Kutz L, Kelley KW, Malarkey WB: Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992;89:7713-7716.
14. Dimattia GE, Gellersen B, Duckworth ML, Friesen HG: Human prolactin gene expression: The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 1990;265:16412-16421.
15. Gellersen B, Kempf R, Telgmann R, Dimattia GE: Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994;8:356-373.
16. Berwaer M, Martial JA, Davis JRE: Characterization of an upstream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994;8:635-642.
17. Berwaer M, Monget P, Peers B, Mathy-Hartert M. Bellefroid E, Davis JR, Belayew A, Martial JA: Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol Cell Endocrinol 1991; 80:53-64.
18. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
19. Luckow B, Schutz G: CAT constructions with multiple unique restriction sites for functional analysis of eukaryotic promoters and regulatory elements. Nucl Acids Res 1987;15:5490.
20. Macgregor GR, Caskey CT: Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res 1989;17: 2365.
21. Manley JL: Transcription of eukaryotic genes in a whole cell extract: in Hames BD, Higgins SJ (eds): Transcription and Translation - A practical Approach. Oxford, IRL Press, 1984, pp 71-87.
22. Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL: Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 1988;7:786-800.
23. Lemaigre FP, Peers B, Lafontaine DA, Mathy-Harter M, Rousseau GG, Belayew A, Martial JA: Pituitary-specific factor binding to the human prolactin, growth hormone and placental lactogen genes. DNA 1989;8:149-159.
24. Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG: A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988;55: 519-529.
25. Howell BW, Lagace M, Shore GC: Activity of the carbamyl phosphate synthetase I promoter in liver nuclear extracts is dependent on a cis-acting C/EBP recognition element. Mol Cell Biol 1989;9:2928-2933.
26. Crenshaw EB III, Kalla K, Simmons DM, Swanson LW, Rosenfeld MG: Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev 1989;3:959-972.
27. Baniahmad A, Muller M, Steiner C, Renkawitz R: Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J 1987;6:2297-2303.
28. Steiner C, Muller M, Baniahmad A, Renkawitz R: Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. Nucleic Acids Res 1987; 15:4163-4178.
29. Hammer RE, Krumlauf R, Camper SA, Brinster RL, Tilghman SM: Diversity of alpha-feto-protein gene expression in mice is generated by combination of separate enhancer elements. Science 1987;235:53-58.
30. Dimattia GE, Rhodes SJ, Krones A, Carrière C, O'Connell S, Kalla K, Arias C, Sawchenko P, Rosenfeld MG: The PIT-1 gene is regulated by distinct early and late pituitary-specific enhancers. Dev Biol 1997;182:180-190.
31. Delhase M, Castrillo J-L, De La Hoya M, Rajas F, Hooghe-Peters EL: AP-1 and Oct-1 transcription factors down-regulate the expression of the human Pit-1/GHF1 gene. J Biol Chem 1996;271:32349-32358.
32. Day RN, Koiske S, Sakan M, Muramatsu M, Maurer RA: Both Pit-1 and estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 1990;4: 1964-1971.
33. Voss JW, Wilson L, Rosenfeld MG: POU-domain proteins Pit-1 and Oct-1 interact to form heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev 1991;5:1309-1320.
34. Schaufele F, West BL, Baxter JD: Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol Endocrinol 1992;6:656-665.
35. Kim MK, McClaskey JH, Bodenner DL, Weintrauh BD: An AP-1 like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of the human thyrotropin B gene expression. J Biol Chem 1993; 268:23366-23375.
36. Lipkin SM, Näär AM, Kalla KA, Sack RA, Rosenfeld MG: Identification of a novel zinc finger protein binding a conversed element critical for Pit-1-dependent growth hormone gene expression. Genes Dev 1993;7:1674-1687.
37. Bach J, Rhodes SJ, Pearse RV, Heinzel T, Glass B, Scully KM, Sawchenko PE, Rosenfeld MG: P-Lim, A LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 1995;92:2720-2724.
38. Szeto DP, Ryan AK, O'Connell SM, Rosenfeld MG: P-OTX: A Pit-1 interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 1996;93:7706-7710.
39. Bradford AP, Wasylik B, Gutierrez-Hartmann A: Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 1997;17:1065-1074.
40. Peers B, Monget P, Nalda AM, Voz ML, Berwaer M, Belayew A, Martial JA: Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1. J Biol Chem 1991;266:18127-18134.
41. Verrijzer CP, Van Oosterhout JA, van Weperen WW, Van der Vliet PC: POU proteins bend DNA via the POU-specific domain. EMBO J 1991;10:3007-3014.
42. Muller M, Berwaer M, Caccavelli L, Manfroid I, Nalda A, Pendeville H, Pernasetti F, van de Weerdt C, Peers B, Martial JA: Regulation transcriptionnelle du gène de la prolactine humaine. Méd Sci 1998;14:580-587.
43. Gellersen B, Kempf R, Telgmann R, DiMattia GE: Pituitary-type transcription of the human prolactin gene in the absence of Pit-1. Mol Endocrinol 1995;9:887-901.
44. Gaasenbeek M, Gellersen B, DiMattia GE: DNasel hypersensitivity analysis of non-pituitary human prolactin gene expression. Mol Cell Endocrinol 1999;152:147-159.
45. Kuo CT, Leiden JM: Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 1999;17:149-187.